GAITHERSBURG, Md., Oct. 11, 2018 — Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 1, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the third quarter of 2018, recent business developments, revenue guidance for the fourth quarter of 2018, and revenue and net income guidance for full year 2018.
This conference call can be accessed live by telephone or by webcast:
Live Teleconference Information: Dial in number: (855) 766-6521 International dial in: (262) 912-6157 Conference ID: 93346559
Live Webcast Information: Visit https://edge.media-server.com/m6/p/u4z3sdn3 for the live webcast feed.
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
About Emergent BioSolutions Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 [email protected]
Media Contact: Lynn Kieffer Vice President, Corporate Communications 240-631-3391 [email protected]